A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data
一项评估普拉西珠单抗治疗早期帕金森病安全性和有效性的II期研究（PASADENA）：研究原理、设计和基线数据
期刊:Frontiers in Neurology
影响因子:2.8
doi:10.3389/fneur.2021.705407
Pagano, Gennaro; Boess, Frank G; Taylor, Kirsten I; Ricci, Benedicte; Mollenhauer, Brit; Poewe, Werner; Boulay, Anne; Anzures-Cabrera, Judith; Vogt, Annamarie; Marchesi, Maddalena; Post, Anke; Nikolcheva, Tania; Kinney, Gene G; Zago, Wagner M; Ness, Daniel K; Svoboda, Hanno; Britschgi, Markus; Ostrowitzki, Susanne; Simuni, Tanya; Marek, Kenneth; Koller, Martin; Sevigny, Jeff; Doody, Rachelle; Fontoura, Paulo; Umbricht, Daniel; Bonni, Azad
